WO2010025577A3 - Zubereitung zur prävention und/oder behandlung und/oder verhinderung der weiterverbreitung von atemwegserkrankungen - Google Patents
Zubereitung zur prävention und/oder behandlung und/oder verhinderung der weiterverbreitung von atemwegserkrankungen Download PDFInfo
- Publication number
- WO2010025577A3 WO2010025577A3 PCT/CH2009/000299 CH2009000299W WO2010025577A3 WO 2010025577 A3 WO2010025577 A3 WO 2010025577A3 CH 2009000299 W CH2009000299 W CH 2009000299W WO 2010025577 A3 WO2010025577 A3 WO 2010025577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- nasal
- spreading
- avoiding
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01431/08A CH699653B1 (de) | 2008-09-08 | 2008-09-08 | Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen. |
CH1431/08 | 2008-09-08 | ||
CH1053/09 | 2009-07-07 | ||
CH01053/09A CH699471B1 (de) | 2008-09-08 | 2009-07-07 | Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010025577A2 WO2010025577A2 (de) | 2010-03-11 |
WO2010025577A3 true WO2010025577A3 (de) | 2010-07-29 |
Family
ID=41797573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CH2009/000299 WO2010025577A2 (de) | 2008-09-08 | 2009-09-07 | Zubereitung zur prävention und/oder behandlung und/oder verhinderung der weiterverbreitung von atemwegserkrankungen |
Country Status (2)
Country | Link |
---|---|
CH (1) | CH699471B1 (pt-PT) |
WO (1) | WO2010025577A2 (pt-PT) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022122175A1 (en) | 2020-12-11 | 2022-06-16 | Herb-Pharma Ag | Antiviral composition comprising cistus and medical device for its administration |
CH719229A1 (de) * | 2021-12-09 | 2023-06-15 | A Vogel Ag | Zusammensetzung zur Prävention und/oder Behandlung und/oder Eindämmung der Weiterverbreitung viraler Zoonosen, inklusive SARS-CoV-2 und deren Varianten. |
GR1010387B (el) * | 2022-02-28 | 2023-01-25 | UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", | Συνδυασμος φυτικων εκχυλισματων με αντι-ιικη δραση με εμφαση στους ιους της γριπης η1ν1 και η3ν2 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4438589A1 (de) * | 1994-10-28 | 1995-03-23 | Reingard Dr Muenster | Nasentherapeutikum |
US20020048551A1 (en) * | 1999-04-06 | 2002-04-25 | Keller Brian C. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
WO2006118459A1 (en) * | 2005-04-29 | 2006-11-09 | Campina Nederland Holding B.V. | Antiviral peptides |
RU2309762C1 (ru) * | 2006-03-28 | 2007-11-10 | Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук | Способ профилактики респираторных болезней телят |
WO2007144676A2 (en) * | 2006-06-13 | 2007-12-21 | Freund Tamas | Use of echinacea or preparations thereof in compositions for the treatment of anxiety |
-
2009
- 2009-07-07 CH CH01053/09A patent/CH699471B1/de unknown
- 2009-09-07 WO PCT/CH2009/000299 patent/WO2010025577A2/de active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4438589A1 (de) * | 1994-10-28 | 1995-03-23 | Reingard Dr Muenster | Nasentherapeutikum |
US20020048551A1 (en) * | 1999-04-06 | 2002-04-25 | Keller Brian C. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
WO2006118459A1 (en) * | 2005-04-29 | 2006-11-09 | Campina Nederland Holding B.V. | Antiviral peptides |
RU2309762C1 (ru) * | 2006-03-28 | 2007-11-10 | Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук | Способ профилактики респираторных болезней телят |
WO2007144676A2 (en) * | 2006-06-13 | 2007-12-21 | Freund Tamas | Use of echinacea or preparations thereof in compositions for the treatment of anxiety |
Non-Patent Citations (5)
Title |
---|
BODINET CORNELIA ET AL: "Effect of oral application of an immunomodulating plant extract on influenza virus type A infection in mice.", PLANTA MEDICA, vol. 68, no. 10, October 2002 (2002-10-01), pages 896 - 900, XP002583063, ISSN: 0032-0943 * |
DATABASE WPI Week 200780, Derwent World Patents Index; AN 2007-869407, XP002583061 * |
GUIOTTO P ET AL: "Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract", PHYTOMEDICINE, GUSTAV FISCHER VERLAG, STUTTGART LNKD- DOI:10.1016/J.PHYMED.2008.05.003, vol. 15, no. 8, 1 August 2008 (2008-08-01), pages 547 - 554, XP022819237, ISSN: 0944-7113, [retrieved on 20080625] * |
PLESCHKA S ET AL: "Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)", VIROLOGY JOURNAL 2009 BIOMED CENTRAL LTD. GBR LNKD- DOI:10.1186/1743-422X-6-197, vol. 6, 2009, XP002583064, ISSN: 1743-422X * |
WOELKART KARIN ET AL: "Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans", PLANTA MEDICA, vol. 74, no. 6, May 2008 (2008-05-01), pages 651 - 656, XP002583062, ISSN: 0032-0943 * |
Also Published As
Publication number | Publication date |
---|---|
CH699471A2 (de) | 2010-03-15 |
WO2010025577A2 (de) | 2010-03-11 |
CH699471B1 (de) | 2010-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011000566A3 (en) | Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections | |
WO2009129470A3 (en) | Methods for treating herpes virus infections | |
WO2011111966A3 (en) | Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses | |
WO2006050489A3 (en) | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions | |
WO2012142093A3 (en) | 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
WO2012065963A3 (en) | Antiviral condensed heterocyclic compounds | |
ZA201108892B (en) | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections | |
WO2011158039A8 (en) | Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (rsv) infection | |
WO2010120524A3 (en) | Methods of modulating an immune response to a viral infection | |
MY141003A (en) | Materials and methods for treating viral infections with a cysteamine compound | |
MX2015012397A (es) | Composiciones y metodos basados en anticuerpos neutralizados suministrados intranasalmente para eficacia terapeutica aumentada. | |
WO2012093258A3 (en) | Irf5- related treatment and screening | |
WO2007089945A3 (en) | Treating diseases by targeting silt3 | |
WO2009094190A3 (en) | Methods of treating viral infections | |
WO2013048153A3 (ko) | 인간 b 세포에서 생산된 인플루엔자 a 바이러스 중화 활성을 가지는 결합 분자 | |
WO2008024843A3 (en) | Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein | |
WO2013059559A3 (en) | Compounds and methods for enhancing innate immune responses | |
CA2862755A1 (en) | Antiviral compounds with a dibenzooxaheterocycle moiety | |
WO2007029041A3 (en) | Interferon lambda therapy for treatment of respiratory diseases | |
MX2013000242A (es) | Tratamiento de enfermedades relacionadas con el virus de hepatitis c que usa hidroxicloroquina o una combinacion de hidroxicloroquina y un agente antiviral. | |
MX354676B (es) | Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv). | |
WO2013058484A3 (ko) | 인제난 타입의 디테르펜 화합물 및 이를 포함하는 바이러스 감염 질환의 치료 또는 예방용 약학적 조성물 | |
WO2013036610A3 (en) | Compositions comprising mg53 and methods for the treatment and prevention of airway injury | |
WO2010025577A3 (de) | Zubereitung zur prävention und/oder behandlung und/oder verhinderung der weiterverbreitung von atemwegserkrankungen | |
MX2012004409A (es) | Proteina recombinante de humano cc10 para el tratamiento de la influenza. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09775786 Country of ref document: EP Kind code of ref document: A2 |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09775786 Country of ref document: EP Kind code of ref document: A2 |